FDA Webview
X
Search
Log In
Home
About Us
Today@FDA
Pay Per View
Free Trial
Contact Us
More
▼
Tell Friend
Subscribe
Free FDA Notices
Guidance on Enrichment Strategies in Trials for NDAs, BLAs
12/17/2012
Categories
Animal Drugs
Biologics
FDA General
Federal Register
Human Drugs
Marketing
Medical Devices
Top News
FDA cites Bausch + Lomb Manufacturing Facility
Amgen New Data Pushes Back Against Proposal to Withdraw Tavneos
FDA Rejects Apiject's NDA for Glycopyrrolate Combination Product
FDA Early Alert Over Boston Scientific Transcarotid Catheter Systems
FDA Advisers Back Expanded Access to Several Compounded Peptides
FDA: PDUFA 7 CMC Commitments Complete
Efforts Needed to Improve Health Outcomes, Califf Says
HELP Committee Advances Biosimilar Bill
LATEST NEWS
Read More
Human Drugs
FDA cites Bausch + Lomb Manufacturing Facility
Read More
Human Drugs
Amgen New Data Pushes Back Against Proposal to Withdraw Tavneos
Read More
Human Drugs
FDA Rejects Apiject's NDA for Glycopyrrolate Combination Product
Read More
Medical Devices
FDA Early Alert Over Boston Scientific Transcarotid Catheter Systems
FDA Webview Free Daily e-Newsletter
Free Sign-Up
